MeSH tree: G04.146.954.035
Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.
Jun 2, 2023
0
117
A new editorial paper was published in Oncotarget's , titled "Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity."
Apr 24, 2023
0
45
The therapeutic potential of microtubule-associated protein targets for cancer therapy is a largely unexplored research area due to a lack of target-specific agents. Sushmita Chatterjee and a research team in nanomedicine, ...
Throughout a woman's reproductive life, the endometrium, the mucous membrane lining the uterus, goes through cyclical remodeling. It thickens during the menstrual cycle in preparation for embryo implantation, and it is shed ...
Apr 10, 2023
0
43
While T cells play a critical role in the immune system by protecting the body against infection and cancer, regulation of T cell activity is necessary to prevent excessive inflammation and damage to healthy tissue.
Mar 28, 2023
0
49
In a new study published in the journal Cardiovascular Innovations and Applications, the authors identified cuproptosis-associated ferroptosis genes in the atherosclerosis microarray of the Gene Expression Omnibus (GEO) database ...
Mar 14, 2023
0
45
While drugs are on the market to slow the progression of neurodegenerative diseases, there are still no cures. But researchers at Boston Children's Hospital and Harvard Medical School are looking for new pathways for slowing ...
Mar 13, 2023
0
251
A study published in the Journal of Orthopaedic Research has identified a bone matrix protein called Secreted phosphoprotein 24 kD (Spp24) that may help to treat osteosarcoma, the most common type of bone cancer.
Mar 8, 2023
0
34
A scientific instrument at the Department of Energy's Oak Ridge National Laboratory could help create a noninvasive cancer treatment derived from a common tropical plant.
Mar 6, 2023
0
311
Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the Garvan Institute of Medical Research shows.
Mar 3, 2023
0
105
